Recombinant Human RB1 Protein，His

RB1, the gene encoding the retinoblastoma protein, plays a crucial role in cell cycle regulation and tumor suppression. Mutations in RB1 are famously linked to retinoblastoma, a pediatric eye cancer, but the implications of RB1 dysregulation extend to various other cancers as well. Research on the RB1 recombinant protein focuses on its structure and function, providing insights into the molecular mechanisms underlying tumorigenesis. Studies have demonstrated that the retinoblastoma protein interacts with a network of other proteins to control the transition from the G1 to S phase of the cell cycle, effectively preventing excessive cell proliferation. Recombining RB1 protein in laboratory settings allows scientists to investigate its interactions, regulatory pathways, and potential as a therapeutic target. Furthermore, advancements in biotechnology enable the production of large quantities of RB1 recombinant protein, facilitating its use in drug development and cancer research. Understanding its role can elucidate cancer pathways, leading to innovative treatment strategies that might resurrect the functional activity of the retinoblastoma pathway in malignancies where it is compromised. Thus, the study of RB1 recombinant protein is not only critical for comprehending the fundamental biology of cancer but also holds the potential for developing therapeutic interventions that could restore normal cell cycle regulation in cancer patients.